A5007074446- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Neutropenia and Cancer Infections
- Diversity and Career in Medicine
- Health Systems, Economic Evaluations, Quality of Life
- Acute Myocardial Infarction Research
- Sex and Gender in Healthcare
- Global Health Workforce Issues
- Chemotherapy-related skin toxicity
- Estrogen and related hormone effects
- Medical Education and Admissions
- Blood disorders and treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cancer, Lipids, and Metabolism
- Innovations in Medical Education
- Medication Adherence and Compliance
- Cardiac Valve Diseases and Treatments
- Cancer Treatment and Pharmacology
- Hematopoietic Stem Cell Transplantation
- Impact of Light on Environment and Health
- scientometrics and bibliometrics research
- Healthcare Policy and Management
- Menopause: Health Impacts and Treatments
- Hereditary Neurological Disorders
Legacy Health
2025
Amgen (United States)
2021-2024
Salisbury NHS Foundation Trust
2023
Health Foundation
2023
American College of Cardiology
2016-2021
Oregon Clinic
2018
Clinical Research Institute
2018
Oregon Medical Research Center
2016
Cardiovascular Institute of the South
1998-2011
AstraZeneca (United States)
2009
Despite the fact that coronary artery disease is leading cause of death among women, previous studies have suggested physicians are less likely to pursue an aggressive approach in women than men. To define this issue further, we compared care previously received by men and who were enrolled a large postinfarction intervention trial.
Cardiovascular multidisciplinary heart teams (MDHTs) have evolved significantly over the past decade. These play a central role in treatment of wide array cardiovascular diseases affecting interventional cardiology, cardiac surgery, imaging, advanced failure, adult congenital disease, cardio-oncology, and cardio-obstetrics. To meet specific needs both patients programs, composition function MDHTs had to adapt evolve. Although lessons been learned from cancer care, best practices for...
Few data exist on internal medicine trainees' selection of cardiology training, although this is important for meeting future workforce needs.To discover professional development preferences and perceptions cardiology, their relationship to career choice.We surveyed trainees the influence those choices. Participants rated 38 needs 19 cardiology. Data collection took place from February 2009, through January 2010. analysis was conducted May 2017 December 2017.Multivariable models were used...
Studies derived from continuous national surveys have shown that the prevalence of diagnosed diabetes mellitus in US is increasing. This study estimated 2004 self-reported diagnosis and other conditions a community-based population, using data Study to Help Improve Early evaluation management risk factors Leading Diabetes (SHIELD).The initial screening questionnaire was mailed stratified random sample 200,000 households US, identify individuals, age > or = 18 years age, with associated...
To investigate the effects of antimalarial chemoprophylaxis and other variables on severity falciparum malaria.Review consecutive malaria cases between 1987 1991.The Hospital for Tropical Diseases, London.250 mild 51 severe malaria.Prophylaxis was taken in 52.4% (131/250) 21.6% (11/51) malaria. Severe more common white patients than those African origin also seen commonly people returning from central, southern, east Africa west Africa. Patients with presented sooner malaria.Prior led to a...
Background The lack of diversity in the cardiovascular physician workforce is thought to be an important driver racial and sex disparities cardiac care. Cardiology fellowship program directors play a critical role shaping cardiology workforce. Methods Results To assess directors' perceptions about barriers enhancing diversity, authors conducted survey 513 or associate from 193 unique adult training programs. response rate was 21% all individuals (110/513) representing 57% US general programs...
Abstract Myelin deficiency in the central nervous system (CNS) can cause severe disabling conditions. Most of transgenic mice models overexpressing myelin components have limitations for investigators and therapy as they severely alter CNS architecture. It has been postulated that transferrin (Tf) is involved oligodendrocyte (OL) maturation myelinogenesis. Because Tf not an intrinsic constituent, we decided to investigate if its overexpression could impact on myelination process without...
Aims: This investigation determined the proportion of adults newly diagnosed as having type-2 diabetes mellitus (T2DM), and ascertained risk predictors for development self-reported T2DM. Methods: The US Study to Help Improve Early evaluation management factors Leading Diabetes (SHIELD) survey was a 5-year longitudinal study with without mellitus. Adults completed baseline health questionnaire in 2004 ≥1 annual follow-up through 2009. Respondents no diagnosis at were followed measure rate...
Abstract Purpose We evaluated the incidence of febrile neutropenia (FN) and related clinical outcomes among patients treated with myelosuppressive chemotherapy for nonmyeloid malignancies who received pegfilgrastim on-body injector (OBI) or other options (Other) FN prophylaxis. Methods In this prospective observational study, adult breast, prostate, lung cancer, non-Hodgkin lymphoma at risk were stratified into subgroups based on prophylaxis used in first cycle: OBI vs Other (pegfilgrastim...
Aim: Trastuzumab-anns is an intravenously administered biosimilar to trastuzumab approved by the EMA and US FDA for treatment of HER2+ early metastatic breast cancer as well gastric cancer. Lack real-world characterization use has hindered uptake. Methods: This observational chart review characterizes 488 patients who received trastuzumab-anns in EU clinical practice settings. Results: Approximately 2/3rds initiated adjuvant neoadjuvant settings most were naive new starters (70%). 30%...
Cardiovascular disease is the leading cause of mortality in women United States. Aggressive treatment modifiable risk factors (e.g., hypercholesterolemia) essential reducing burden. Despite guidelines recommending use statin hypercholesterolemic women, this patient group often undertreated. This subgroup analysis Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin (STELLAR) trial examines effects therapy women.As part STELLAR trial, 1,146 with elevated...
Guidelines recommend antihypertensive, lipid-lowering and/or antiplatelet therapy for prevention of cardiovascular disease (CVD). This study examined the utilisation therapies among individuals at CVD risk to assess adherence guidelines.Respondents SHIELD were classified based on National Cholesterol Education Program Adult Treatment Panel III categories. High coronary heart (CHD) (n = 7510) was defined as self-reported diagnosis disease/heart attack, narrow or blocked arteries, stroke...